skip to Main Content

The LIMIting AAA with meTformin (LIMIT) Trial

This study will test the ability of metformin XR (extended release) to reduce the rate of enlargement of existing small- to medium-size abdominal aortic aneurysms with an effect size of 30% compared to placebo and assess the safety and tolerance of daily metformin XR therapy in non-diabetic abdominal aortic aneurysm patients.

Investigator: Chang, Robert

Funder: National Heart, Lung, and Blood Institute

Explore all studies and publications

Back To Top